Relay Therapeutics, Inc.RLAYNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank71
3Y CAGR-57.3%
5Y CAGR+15.9%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-57.3%/yr
Annual compound
5Y CAGR
+15.9%/yr
Recent deceleration
Percentile
P71
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 94.54 | +60.7% |
| 2024 | 58.82 | +11.3% |
| 2023 | 52.83 | -95.6% |
| 2022 | 1214.17 | +25.9% |
| 2021 | 964.56 | +2030.2% |
| 2020 | 45.28 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |